RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway–Dependent Tumors

Cancer Research
July 1, 2015
Cited by 167


Related Papers

No related papers found

Powered by citation graph analysis